p-SCN-Bn-DOTA

ComMedX is a platform company focused on computational chemistry-driven drug research and development. Utilizing leading global technologies such as large-scale virtual screening based on protein three-dimensional structures and artificial intelligence, we provide early-stage development services for small molecule innovative drugs to pharmaceutical companies and research institutions worldwide. Our services rapidly identify and optimize lead compounds, addressing the urgent needs for small molecule drug development from concept to reality. Our core technology team, hailing from the University of California, San Francisco and the Beijing Institute of Life Sciences, aims to industrialize scientific research findings by integrating cutting-edge technologies from biology, chemistry, pharmacy, and computer science, thereby accelerating the development of original innovative drugs.